Medical Microinstruments completes first case in neurosurgical trial with MMI Symani system - The Robot Report

Medical Microinstruments Inc. (MMI) has completed the first neurosurgical cases using its Symani Surgical System in a clinical trial sponsored by the Jacobs Institute at Buffalo General Medical Center. The Symani system features a portable cart with a macropositioner and micromanipulators offering seven degrees of freedom, designed to enhance precision in delicate microsurgical procedures. This milestone builds on a 2024 preclinical study and demonstrates the system’s ability to perform highly skilled maneuvers in neurosurgery, potentially surpassing human manual capabilities. MMI aims to expand robotic microsurgery into complex areas such as neurovascular disease treatment, with the goal of reducing stroke, seizures, paralysis, and vision problems. The system combines wristed micro-instruments with tremor reduction and motion scaling and has been used in over 2,000 cases globally, primarily in lymphatic surgery. Although FDA-authorized for general use in the U.S. and CE-marked in Europe, the Symani system has